Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
Messina, Julia A.; Cheng, Su-Chun; Franc, Benjamin L.; Charron, Martin; Shulkin, Barry L.; To, Bao; Maris, John M.; Yanik, Gregory A.; Hawkins, Randall A.; Matthay, Katherine K.
2006-12
Citation
Messina, Julia A.; Cheng, Su-Chun; Franc, Benjamin L.; Charron, Martin; Shulkin, Barry; To, Bao; Maris, John M.; Yanik, Gregory; Hawkins, Randall A.; Matthay, Katherine K. (2006). "Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma." Pediatric Blood & Cancer 47(7): 865-874. <http://hdl.handle.net/2027.42/55847>
Abstract
Background The purpose of this study was to determine the accuracy of two semi-quantitative scoring systems to assess response to 131 I-metaiodobenzylguanidine (mIBG) therapy in recurrent neuroblastoma. Procedures Diagnostic mIBG scan pairs (n = 57) were collected for patients who underwent 131 I-mIBG therapy for relapsed neuroblastoma. Two scoring systems were designated: Method 1, which divided the body into nine segments to view osteomedullary lesions with an additional tenth segment to assess soft tissue involvement; and Method 2, which divided the body into seven segments without a corresponding compartment for soft tissue involvement. Four nuclear medicine physicians independently assigned extension and intensity scores utilizing both methods, and separately recorded their impression of whether the post-therapy scan had improved, not changed, or worsened. Inter- and intra-observer concordance and correlation with overall response and progression-free survival (PFS) were performed. Results Method 1 produced the highest inter-observer concordance and was used to calculate the relative extension scores (post-therapy score divided by pre-therapy score), which correlated significantly with overall response. Patients who achieved complete response (CR) or partial response (PR) (n = 21) had lower relative extension scores, compared to those without response ( P < 0.001). The readers' overall impression associated highly ( P < 0.001) with the relative extension scores though results were less quantitative. Concordance was higher if initial scores were >5. Relative extension score did not predict PFS. Conclusion Semi-quantitative scoring of mIBG scans provides a more reliable method of assessing response in patients with relapsed neuroblastoma than qualitative impression. The reproducibility and high inter-observer concordance makes mIBG score an important component of overall response criteria in patients with recurrent neuroblastoma. Pediatr Blood Cancer © 2006 Wiley-Liss, Inc.Publisher
Wiley Subscription Services, Inc., A Wiley Company
ISSN
1545-5009 1545-5017
Other DOIs
PMID
16444675
Types
Article
URI
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16444675&dopt=citationMetadata
Show full item recordRemediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.